SHR-1701

Tax included
SHR-1701 (Retlirafusp alfa) is a bifunctional fusion protein targeting PD-L1 and TGF-β for cancer research.
MedChemExpress 
HY-P99944

Data sheet

Size
Multiple sizes
Reactivity
PD-1/PD-L1; TGF-β Receptor
Application
Cancer-Kinase/protease
CAS
2891860-17-4